Rat Urinary Bladder Carcinogenesis by Dual-Acting PPARα+γ Agonists

Despite clinical promise, dual-acting activators of PPARα and γ (here termed PPARα+γ agonists) have experienced high attrition rates in preclinical and early clinical development, due to toxicity. In some cases, discontinuation was due to carcinogenic effect in the rat urothelium, the epithelial lay...

Full description

Saved in:
Bibliographic Details
Main Authors: Martin B. Oleksiewicz, Jennifer Southgate, Lars Iversen, Frederikke L. Egerod
Format: Article
Language:English
Published: Wiley 2008-01-01
Series:PPAR Research
Online Access:http://dx.doi.org/10.1155/2008/103167
Tags: Add Tag
No Tags, Be the first to tag this record!